Aurinia Pharmaceuticals Inc. achieved record Lupkynis sales of $66.6M in Q2 while managing cash flow. Click for insights on ...

Invivoscribe has a successful track record of partnerships with pharmaceutical companies interested in clinical trial testing via our global lab network located in the U.S., Germany, Japan and ...

Main Street Enid would like us to think about what the city could look like if our focus wasn’t so much on what it takes to get through town but ...

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial ...

Chart Industries Inc. (NYSE:GTLS) is one of the 10 most undervalued industrial stocks to buy according to analysts.

Chart Industries Inc. and Flowserve Corp. agreed June 4 to combine in an all-stock merger, creating a differentiated leader in industrial process technologies. The combined company is expected to be ...

Chart Industries and Flowserve recently agreed to merge in an all-stock deal. The two companies outlined significant revenue and cost synergies. Strangely, both bargain-priced stocks fell after ...

Winston & Strawn and Cravath steered a $19 billion deal to merge industrial companies Chart Industries Inc. and Flowserve Corp.

U.S.-based equipment manufacturer Chart Industries and flow control systems maker Flowserve Corp agreed to merge in an all-stock deal, valuing the combined company at about $19 billion.

Two businesses in industrial-process technologies struck an all-stock merger worth roughly $19 billion. Chart Industries GTLS 0.16% and Flowserve FLS -0.13% said Wednesday they plan to combine in ...

Industrial companies Chart Industries Inc. and Flowserve Corp. agreed to merge in a deal valuing the combined company at about $19 billion.

By Colin Kellaher Shares of Chart Industries and Flowserve moved lower in premarket trading Wednesday after the companies agreed to combine in an all-stock merger.